The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor
Abstract
OBJECTIVE: Progesterone binds to the human mineralocorticoid receptor (hMR) with nearly the same affinity as do aldosterone and cortisol, but confers only low agonistic activity. It is still unclear how aldosterone can act as a mineralocorticoid in situations with high progesterone concentrations, e.g. pregnancy. One mechanism could be conversion of progesterone to inactive compounds in hMR target tissues. DESIGN: We analyzed the agonist and antagonist activities of 16 progesterone metabolites by their binding characteristics for hMR as well as functional studies assessing transactivation. METHODS: We studied binding affinity using hMR expressed in a T7-coupled rabbit reticulocyte lysate system. We used co-transfection of an hMR expression vector together with a luciferase reporter gene in CV-1 cells to investigate agonistic and antagonistic properties. RESULTS: Progesterone and 11beta-OH-progesterone (11beta-OH-P) showed a slightly higher binding affinity than cortisol, deoxycorticosterone and aldosterone. 20alpha-dihydro(DH)-P, 5alpha-DH-P and 17alpha-OH-P had a 3- to 10-fold lower binding potency. All other progesterone metabolites showed a weak affinity for hMR. 20alpha-DH-P exhibited the strongest agonistic potency among the metabolites tested, reaching 11.5% of aldosterone transactivation. The agonistic activity of 11beta-OH-P, 11alpha-OH-P and 17alpha-OH-P was 9, 5.1 and 4.1% respectively. At a concentration of 100 nmol/l, progesterone, 17alpha-OH-P and 20alpha-DH-P inhibit nearly 75, 40 and 35% of the transactivation by aldosterone respectively. All other progesterone metabolites tested demonstrate weaker affinity, and agonistic and antagonistic potency. CONCLUSIONS: The binding affinity for hMR and the agonistic and antagonistic activity diminish with increasing reduction of the progesterone molecule at C20, C17 and at ring A. We assume that progesterone metabolism to these compounds is a possible protective mechanism for hMR. 17alpha-OH-P is a strong hMR antagonist and could exacerbate mineralocorticoid deficiency in patients with congenital adrenal hyperplasia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the transactivation activities of progesterone and 17OHP were only 0.2 to 0.8% of that for cortisol, whereas the transactivation activity of 21-deoxycortisol was 8.5% and 17% in two different assays (137,138).”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [138]
In the citing paper
“In vitro, 21-deoxycortisol, corticosterone, 17OHP, and progesterone bind the glucocorticoid receptor with 24-43% of the affinity of cortisol.”
From Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management (2022) · cites this paper as [138]
Citations
Cites
THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
Scatchard, G. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb27297.x · Cited by 19,724
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Arriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Edwards, C. R. W., Burt, D., McIntyre, M., de Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,067
Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy
Geller, D. S., Farhi, A., Pinkerton, N., Fradley, M., Moritz, M., Spitzer, A., Meinke, G., Tsai, F. T. F., Sigler, P. B., & Lifton, R. P. (2000) · Science · doi:10.1126/science.289.5476.119 · Cited by 675
Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure
Oelkers, W. K. H. (1996) · Steroids · doi:10.1016/0039-128x(96)00007-4 · Cited by 333
Self-citationRupprecht, R., Reul, J. M. H. M., van Steensel, B., Spengler, D., Söder, M., Berning, B., Holsboer, F., & Damm, K. (1993) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(93)90072-h · Cited by 297
Multiple aspects of mineralocorticoid selectivity
Farman, N., & Rafestin-Oblin, M.-E. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.280.2.f181 · Cited by 268
Cited by
Sorted by citations
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Stanczyk, F. Z., Hapgood, J. P., Winer, S., & Mishell, D. R. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1008 · Cited by 429
“However, the anti-MR effects of progesterone may be relevant only when endogenous progesterone concentrations are high, such as during the luteal phase of the menstrual cycle and pregnancy, because progesterone has a short half-life and is rapidly converted to metabolites without anti-MR activity (199).”
BackgroundThe Mineralocorticoid Receptor: Insights into its Molecular and (Patho)Physiological Biology
Viengchareun, S., Menuet, D. L., Martinerie, L., Munier, M., Tallec, L. P.-L., & Lombès, M. (2007) · Nuclear Receptor Signaling · doi:10.1621/nrs.05012 · Cited by 342
“It is now clear that progesterone and androgens and their derivatives could also bind MR and exert partial agonist and antagonist effects depending on the cellular context [Marissal-Arvy et al., 2004; Quinkler et al., 2002; Quinkler et al., 2003; Takeda et al., 2007].”
Africander, D., Verhoog, N. J. D., & Hapgood, J. P. (2011) · Steroids · doi:10.1016/j.steroids.2011.03.001 · Cited by 244
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Grossmann, C., Scholz, T., Rochel, M., Bumke-Vogt, C., Oelkers, W., Pfeiffer, A., Diederich, S., & Bahr, V (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510397 · Cited by 212
“A good example for this notion is progesterone (Table 3), which has been shown to possess high affinity to the hMR but causes only minor transactivation at the MR ( 33 , 38) and acts as an antagonist in vivo (44).”
BackgroundThe brain mineralocorticoid receptor and stress resilience
ter Heegde, F., De Rijk, R. H., & Vinkers, C. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.022 · Cited by 187
Physiological partial aldosterone resistance in human newborns
Martinerie, L., Pussard, E., Foix-L'Hélias, L., Petit, F., Cosson, C., Boileau, P., & Lombès, M. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181b1bbec · Cited by 148
“This indicates that neonatal natremia is independent from maternal natremia that may be related to pregnancy hemodilution (17) or mineralocorticoid antagonism by high levels of progesterone during late gestation (18).”
BackgroundResultCaprio, M., Antelmi, A., Chetrite, G., Muscat, A., Mammi, C., Marzolla, V., Fabbri, A., Zennaro, M., & Fève, B. (2010) · Endocrinology · doi:10.1210/en.2010-0674 · Cited by 139
The cortisol switch between vulnerability and resilience
de Kloet, E. R., & Joëls, M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01934-8 · Cited by 161
“MR is promiscuous and binds with high af fi nity, besides CORT, the mineralocorticoids aldosterone, deoxycorticosterone as well as progesterone [16].”
Klok, M. D., Giltay, E. J., van der Does, W. A. J., Geleijnse, J. M., Antypa, N., Penninx, B. W. J. H., de Geus, E. J. C., Willemsen, G. A. H. M., Boomsma, D. I., van Leeuwen, N., et al. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.59 · Cited by 132
“Moreover, estrogens and progesterone are known to modulate MR mRNA and/or protein expression, with possible consequences for stress-reactivity.(40,41) These effects of sex steroids are superimposed on the remarkable promiscuity of the brain MR, which can bind also aldosterone and progesterone, but is particularly occu…”
BackgroundRelationship between Aldosterone and Progesterone in the Human Menstrual Cycle
Szmuilowicz, E. D., Adler, G. K., Williams, J. S., Green, D. E., Yao, T. M., Hopkins, P. N., & Seely, E. W. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1154 · Cited by 107
“Increased luteal phase aldosterone levels are thought to result from increased progesterone, which has known antimineralocorticoid effects (1, 2, 3, 16).”
BackgroundHultman, M. L., Krasnoperova, N. V., Li, S., Du, S., Xia, C., Dietz, J. D., Lala, D. S., Welsch, D. J., & Hu, X. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0537 · Cited by 100
Leo, J. C. L., Guo, C., Woon, C. T., Aw, S. E., & Lin, V. C. L. (2003) · Endocrinology · doi:10.1210/en.2003-0732 · Cited by 96
Analysis of baseline parameters in the HALT polycystic kidney disease trials
Torres, V. E., Chapman, A. B., Perrone, R. D., Bae, K. T., Abebe, K. Z., Bost, J. E., Miskulin, D. C., Steinman, T. I., Braun, W. E., Winklhofer, F. T., et al. (2011) · Kidney International · doi:10.1038/ki.2011.411 · Cited by 91
“The positive correlation between urine aldosterone excretion and eGFR and the lower urinary aldosterone excretion in Study B compared with Study A participants, despite higher serum potassium concentrations, suggests that as renal function declines extracellular fluid volume expansion suppresses the circulating RAS.”
BackgroundThe human kidney is a progesterone-metabolizing and androgen-producing organ
Quinkler, M., Bumke-Vogt, C., Meyer, B., Bähr, V., Oelkers, W., & Diederich, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021970 · Cited by 87
Self-citationVinkers, C. H., Joëls, M., Milaneschi, Y., Gerritsen, L., Kahn, R. S., Penninx, B. W. J. H., & Boks, M. P. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.01.018 · Cited by 83
“First, sex-dependent effects are plausible from a biological perspective as the female steroid hormones estrogen and progesterone both display MR affin-ity and can affect HPA axis activity (Carey et al., 1995; Quinkler et al., 2002).”
Piani, F., Melena, I. L., Tommerdahl, K. L., Nokoff, N., Nelson, R. G., Pavkov, M. E., van Raalte, D. H., Cherney, D. Z. I., Johnson, R. J., Nadeau, K. J., et al. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107841 · Cited by 78
“5% of aldosterone transactivation, while 17alpha-OH-progesterone has shown to be a strong mineral corticoid receptor antagonist [78].”
BackgroundOng, G. S. Y., & Young, M. J. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0318 · Cited by 78
Chortatos, A., Haugen, M. A., Iversen, P., Vikanes, Å. V., Magnus, P. M., & Veierød, M. B. (2013) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12406 · Cited by 69
Cortisol boosts risky decision-making behavior in men but not in women
Kluen, L. M., Agorastos, A., Wiedemann, K., & Schwabe, L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.07.240 · Cited by 64
“Furthermore, estrogen may affect the expression of receptors for glucocorticoids (Quinkler et al., 2002).”
BackgroundRiepe, F. G., Finkeldei, J., SANCTIS, L. D., Einaudi, S., Testa, A., Karges, B., Peter, M., Viemann, M., Grötzinger, J., Sippell, W. G., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1161 · Cited by 67
“Aldosterone binding characteristics were evaluated as previously described (22).”
BackgroundQuantitation of Glucocorticoid Receptor DNA-Binding Dynamics by Single-Molecule Microscopy and FRAP
Groeneweg, F. L., van Royen, M. E., Fenz, S. F., Keizer, V. I. P., Geverts, B., Prins, J., de Kloet, E. R., Houtsmuller, A. B., Schmidt, T. S., & Schaaf, M. J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090532 · Cited by 63
“In the present study, we show that the 11-hydroxyl group affects the mobility of the MR (there is a difference between the effects of corticosterone and deoxycorticosterone), but it has been shown not to alter the receptor binding affinity [55].”
BackgroundAbnormal steroidogenesis and aromatase activity in preeclampsia
Berkane, N. B., Lière, P., Lefèvre, G., Alfaidy, N., Nahed, R. A., Vincent, J., Oudinet, J., Pianos, A., Cambourg, A., Rozenberg, P., et al. (2018) · Placenta · doi:10.1016/j.placenta.2018.07.004 · Cited by 56
Sex differences in cortisol levels in depression: A systematic review and meta-analysis
Wang, R., Kogler, L., & Derntl, B. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101118 · Cited by 58
ter Horst, J. P., Carobrez, A. P., van der Mark, M. H., de Kloet, E. R., & Oitzl, M. S. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2012.08237.x · Cited by 59
“In addition, estrogens affect the synthesis of the MR, while progesterone displays affinity to these receptors (Carey et al., 1995; Quinkler et al., 2002), which could also influence the stress reaction.”
BackgroundStress & executive functioning: A review considering moderating factors
Plieger, T., & Reuter, M. (2020) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2020.107254 · Cited by 73
Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues
Sharma, K. K., Lindqvist, A., Zhou, X. J., Auchus, R. J., Penning, T. M., & Andersson, S. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.024 · Cited by 57
Ruffaner‐Hanson, C. D., Noor, S., Sun, M. S., Solomon, E. R., Marquez, L. E., Rodriguez, D. E., Allan, A. M., Caldwell, K. K., Bakhireva, L. N., & Milligan, E. D. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114121 · Cited by 56
“…glucocorticoids, it can promote glucocorticoid displacement from CBG, resulting in elevated free biologically active glucocorticoids to occupy GR and MR, that may result in adverse fetal glucocorticoid resistance in the periphery (Quinkler et al., 2002; McMaster and Ray, 2008; Kamoun et al., 2014).”
BackgroundThe multifaceted mineralocorticoid receptor
Gomez‐Sanchez, E., & Gomez‐Sanchez, C. E. (2014) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2014.tb00569.x · Cited by 55
“Progesterone also has high affinity for the MR and circulates in relevant concentrations to compete with aldosterone in pregnancy and the luteal phase (364).”
Two Panels of Steroid Receptor Luciferase Reporter Cell Lines for Compound Profiling
Sedlák, D., Paguio, A., & Bartůněk, P. (2011) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620711795222446 · Cited by 52
“We also compared data generated with our cell lines to values in the literature and found our data comparable to literature reports for all receptor/promoter combinations [11, 12, 14, 19-21].”
ResultMineralocorticoid substitution and monitoring in primary adrenal insufficiency
Quinkler, M. O., Oelkers, W., Remde, H., & Allolio, B. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2014.08.008 · Cited by 53
Glucocorticoid-Related Signaling Effects in Vascular Smooth Muscle Cells
Molnár, G. A., Lindschau, C., Dubrovska, G., Mertens, P. R., Kirsch, T., Quinkler, M. O., Gollasch, M., Wresche, S., Luft, F. C., Müller, D. N., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.105718 · Cited by 51
Mineralocorticoid receptor haplotype, oral contraceptives and emotional information processing
Hamstra, D. A., de Kloet, E. R., van Hemert, A. M., Rijk, R. H. D., & van der Does, W. A. J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.12.004 · Cited by 50
“Previous studies in rats revealed that endogenous estrogen and particularly progesterone affect the expression and binding characteristics of the MR in the brain, which may explain the effects of the MR on HPA axis activity (Carey et al. 1995; Quinkler et al., 2002).”
BackgroundOral contraceptives positively affect mood in healthy PMS-free women: A longitudinal study
Hamstra, D. A., de Kloet, E. R., de Rover, M., & Van der Does, W. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.10.011 · Cited by 41
Armanini, D., Bordin, L., Donà, G., Sabbadin, C., Bakdounes, L., Ragazzi, E., Giorgino, F. L., & Fiore, C. (2012) · Steroids · doi:10.1016/j.steroids.2012.02.010 · Cited by 45
“The effective affinity of progesterone forMR is in vivo 10–30-fold less than that of aldosterone, reflecting its much higher plasma binding; despite this, the concentration of progesterone in the luteal phase may protect the vessels and heart from effect of increased aldosterone [16].”
BackgroundZheng, W., Shi, M., You, S.-E., Ji, H., & Roesch, D. M. (2006) · Gender Medicine · doi:10.1016/s1550-8579(06)80193-2 · Cited by 43
Swart, A. C., Storbeck, K., & Swart, P. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.014 · Cited by 44
Bothou, C., Anand, G., Li, D., Kienitz, T., Seejore, K., Simeoli, C., Ebbehoj, A., Ward, E. G., Paragliola, R. M., Ferrigno, R., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa266 · Cited by 44
“during pregnancy is affected by the mineralocorticoid antagonistic action of progesterone (21,22).”
BackgroundSelf-citationSex Steroids Localized to the Amygdala Increase Pain Responses to Visceral Stimulation in Rats
Myers, B., Schulkin, J. A., & Meerveld, B. G. (2010) · Journal of Pain · doi:10.1016/j.jpain.2010.10.007 · Cited by 43
Fommei, E., Ghione, S., Ripoli, A., Maffei, S., Cecco, P. D., Iervasi, A., & Turchi, S. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.109 · Cited by 43
Mineralocorticoid receptor haplotype, estradiol, progesterone and emotional information processing
Hamstra, D. A., de Kloet, E. R., Quataert, I., Jansen, M., & van der Does, W. A. J. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.11.037 · Cited by 42
“Progesterone (P4) binds to the MR with nearly the same affinity as aldosterone and cortisol, and acts as a competitive antagonist (Quinkler et al., 2002; Carey et al., 1995).”
Progesterone potentially degrades to potent androgens in surface waters
Ojoghoro, J. O., Chaudhary, A. J., Campo, P., Sumpter, J. P., & Scrimshaw, M. D. (2016) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2016.11.176 · Cited by 41
“The production rate and blood plasma levels of P4 are highest in females of reproductive age and during pregnancy (Quinkler et al., 2002).”
Gent, R., du Toit, T., Bloem, L. M., & Swart, A. C. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.02.013 · Cited by 41
Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity?
Hermsmeyer, R. K., Thompson, T. L., Pohost, G. M., & Kaski, J. C. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1234 · Cited by 40
“There is, however, only one unique, naturally occurring hormone known as progesterone, which is a specific chemical entity that belongs to the class of progestins”
BackgroundBumke‐Vogt, C., Bähr, V., Diederich, S., Herrmann, S.-M., Anagnostopoulos, I., Oelkers, W., & Quinkler, M. O. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750349 · Cited by 39
Update on adrenal insufficiency: diagnosis and management in pregnancy
Langlois, F., Lim, D. S. T., & Fleseriu, M. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000331 · Cited by 39
Quinkler, M. O., Meyer, B., Oelkers, W., & Diederich, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030092 · Cited by 39
Enteric Microbiota–Gut–Brain Axis from the Perspective of Nuclear Receptors
Duszka, K., & Wahli, W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082210 · Cited by 37
“In addition to MCs and GCs, progesterone is a competitive MR antagonist with a similar affinity for the MR as aldosterone [596].”
BackgroundRegulation of activities of steroid hormone receptors by tibolone and its primary metabolites
Escande, A., Servant, N., Rabenoelina, F., Auzou, G., Kloosterboer, H. J., Cavaillès, V., Balaguer, P., & Maudelondé, T. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.03.008 · Cited by 32
“The same group has also shown that 17α-OH-Progesterone has a lower affinity than progesterone for the MR but a much lower mineralocorticoid agonist activity. and expresses antagonistic activity (Quinkler et al, 2002).”
BackgroundBarnard, L., du Toit, T., & Swart, A. C. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111189 · Cited by 30
Bonapersona, V., Damsteegt, R., Adams, M. L., van Weert, L. T. C. M., Meijer, O. C., Joëls, M., & Sarabdjitsingh, R. A. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00181 · Cited by 32
Fluid and electrolyte balance considerations for female athletes
Rodriguez‐Giustiniani, P., Rodríguez-Sánchez, N., & Galloway, S. D. R. (2021) · European Journal of Sport Science · doi:10.1080/17461391.2021.1939428 · Cited by 34
“Thus, progesterone is postulated to mediate the observed luteal phase increase in aldosterone concentration (Quinkler et al., 2002).”
Background16α-Hydroxyprogesterone: Origin, biosynthesis and receptor interaction
Storbeck, K., Swart, P., Africander, D., Conradie, R., Toit, R. L.-D., & Swart, A. C. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.016 · Cited by 28
Mooij, C. F., Parajes, S., Pijnenburg-Kleizen, K. J., Arlt, W., Krone, N., & Claahsen-van der Grinten, H. L. (2015) · Hormone Research in Paediatrics · doi:10.1159/000374112 · Cited by 27
Maternal Adaptations to Pregnancy
Thornburg, K. L. R., Bagby, S. P., & Giraud, G. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00043-0 · Cited by 27
Galigniana, M. D., Pilipuk, G. P., Kanelakis, K. C., Burton, G., & Lantos, C. P. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.041 · Cited by 26
“the MR-dependent activity of a gene-reporter in transiently transfected cell lines (Grassi et al., 1997; Agarwal and Mirashi, 2000; Piwien-Pilipuk et al., 2002a; Quinkler et al., 2002), which evidences the enormous differences that can be obtained by working with an integrated biological effect under in vivo condition…”
BackgroundCardiac effects of aldosterone: Does gender matter?
Mihailidou, A. S., & Ashton, A. W. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.013 · Cited by 26
“There are suggestions that increased aldosterone production is secondary to increased progesterone [42,44], competing with aldosterone for MR [50–52].”
Association between arterial properties and renal sodium handling in a general population.
Seidlerová, J., Staessen, J. A., Maillard, M., Nawrot, T., Zhang, H., Bochud, M., Kuznetsova, T., Richart, T., Van Bortel, L. M., Struijker-Boudier, H. A., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000240516.60040.ba · Cited by 25
Balsamo, A., Cicognani, A., Gennari, M., Sippell, W. G., Menabò, S., Baronio, F., & Riepe, F. G. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02330 · Cited by 25
“Aldosterone binding characteristics were determined as previously described ( 22 ).”
BackgroundGómez-Sánchez, E. P., Gomez-Sanchez, M. T., de Rodriguez, A. F., Romero, D. G., Warden, M. P., Plonczynski, M. W., & Gómez-Sánchez, C. E. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953059 · Cited by 24
Sex and Gender Related Differences in Diabetic Kidney Disease
Sridhar, V. S., Yau, K., Benham, J. L., Campbell, D. J. T., & Cherney, D. Z. I. (2022) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2022.04.007 · Cited by 23
Nakao, H., Yokomoto‐Umakoshi, M., Nakatani, K., Umakoshi, H., Ogata, M., Fukumoto, T., Kaneko, H., Iwahashi, N., Fujita, M., Ogasawara, T., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104733 · Cited by 24
Vecchiola, A., Uslar, T., Friedrich, I., Aguirre, J., Sandoval, A., Carvajal, C. A., Tapia-Castillo, A., Martínez, A., & Fardella, C. (2024) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000305 · Cited by 20
“…local inactivation of the progesterone pre-receptor by the enzyme 20-alpha-hydroxysteroid-dehydrogenase (AKR1C1), which converts progesterone to inactive 20-hydroxy-progesterone [58], exhibits reduced affinity for the human mineralocorticoid receptor (Ki 10.8 nM and IC50 282.5 nM) [51,59,60] (Fig.”
BackgroundInfluentialWolak, T., Sergienko, R., Wiznitzer, A., Shlush, L. B., Paran, E., & Sheiner, E. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903544736 · Cited by 21
“However, the high levels of progesterone act as minerlocorticoid receptor blocker [24] and by that decrease, the full effect of aldosterone on the kidney and severe potassium wasting is avoided [8].”
BackgroundQing, L.-L., Liu, L.-L., Zhou, L., Zhang, F., Gao, C.-Q., Hu, L.-P., & Nie, S.-J. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113318 · Cited by 16
Role of TGF-β signalling in PCOS associated focal segmental glomerulosclerosis
Bhati, M., Prabhu, Y. D., Renu, K., Vellingiri, B., Thiagarajan, P., Panda, A., Chakraborty, R., Myakala, H., & Gopalakrishnan, A. V. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.07.032 · Cited by 18
Simard, M., Côté, M., Provost, P. R., & Tremblay, Y. (2010) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-8-134 · Cited by 15
“In addition, based on the reported affinity of deoxycorticosterone for the mineralocorticoid receptor [47] and on the very low aldosterone synthase mRNA level in fetal lungs ([22] and data not shown), one would suggest that this steroid could have also mineralocorticoid effects in the lung.”
BackgroundTschaidse, L., Reisch, N., Arlt, W., de la Perrière, A. B., Hirschberg, A. L., Juul, A., Mallappa, A., Merke, D. P., Newell-Price, J. D. C., Perry, C. G., et al. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvac006 · Cited by 15
“13 These studies revealed that 17OHP binds well to the hMR (Ki = 16.5 nmol L –1 ), possesses only a weak agonistic effect (ED 50 > 1000 nmol L –1 ), but a strong antagonistic effect with an IC 50 of 135 nmol L –1 .”
BackgroundInfluentialGomes, L. G., Madureira, G., Mendonca, B. B., & Bachega, T. A. S. S. (2013) · Clinics · doi:10.6061/clinics/2013(02)oa05 · Cited by 15
“Additionally, in 21OHD patients, the accumulated androgen precursors, progesterone and 17OH-progesterone (17OHP) inhibit mineralocorticoid receptor transactivation by aldosterone (20).”
BackgroundLuteal Lipid Droplets: A Novel Platform for Steroid Synthesis
Plewes, M. R., Talbott, H. A., Saviola, A. J., Woods, N. T., Schott, M. B., & Davis, J. S. (2023) · Endocrinology · doi:10.1210/endocr/bqad124 · Cited by 14
Mitchell, V. E., & Welling, L. L. M. (2020) · Adaptive Human Behavior and Physiology · doi:10.1007/s40750-020-00137-1 · Cited by 15
Sex Differences in Kidney Health and Disease
Harvey, B. J., & de la Rosa, D. Á. (2024) · The Nephron journals/Nephron journals · doi:10.1159/000541352 · Cited by 20
Combined Liquid Chromatography–Tandem Mass Spectrometry Analysis of Progesterone Metabolites
Sinreih, M., Zukunft, S., Sosič, I., Cesar, J., Gobec, S., Adamski, J., & Rižner, T. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117984 · Cited by 13
“Furthermore, progesterone metabolites have weak affinity for human mineralocorticoid receptors and can demonstrate either agonistic or antagonistic effects, although the main role of progesterone metabolism in the kidney, especially during pregnancy, is the protection of the mineralocorticoid receptor against high pro…”
BackgroundPeristera, O., Spreafico, M., Smieško, M., Ernst, B., & Vedani, A. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.05.025 · Cited by 12
“The experimental affinity data were obtained from three different sources (Grassy et al., 1997; Quinkler et al., 2002; Neel et al., 2005).”
BackgroundMethodInfluentialMaternal Adaptation to Pregnancy
Thornburg, K. L. R., Bagby, S. P., & Giraud, G. D. (2006) · Elsevier eBooks · doi:10.1016/b978-012515400-0/50059-2 · Cited by 12
Chen, X., Huang, M., Chen, Y., Xu, H., & Wu, M. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10455-1 · Cited by 12
van Diepen, H. A., Lam, T. W., & Kuil, C. W. (2011) · Contraception · doi:10.1016/j.contraception.2010.11.017 · Cited by 11
“0 nmol/L) using CV-1 cells transfected with hMR and the luciferase reporter gene [28].”
MethodAdrenal insufficiency in pregnancy: Physiology, diagnosis, management and areas for future research
Lee, J. H., & Torpy, D. J. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09745-6 · Cited by 13
“Contributing factors to this altered fluid homeostasis include vasodilatation from uteroplacental derived prostaglandins which inhibit the effect of increased angiotensin II [48], and progesterone’s action as a mineralocorticoid receptor antagonist [49].”
BackgroundHammami, M. M., Duaiji, N., Mutairi, G., Aklabi, S., Qattan, N., Abouzied, M., & Sous, M. W. (2015) · BMC Cancer · doi:10.1186/s12885-015-1620-3 · Cited by 11
“Progesterone exhibits the same affinity as aldosterone for the human mineralocorticoid receptor, acting as antagonist [16].”
BackgroundDoes Stress Elicit Depression? Evidence From Clinical and Preclinical Studies
Sickmann, H. M., Li, Y., Mørk, A., Sánchez, C., & Gulinello, M. E. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_292 · Cited by 10
“Progestins can also bind to both the MR and the GR (Myles and Funder 1996; Quinkler et al. 2002).”
Renal tubular acidosis type 4 in pregnancy
Jakes, A. D., Baynes, K., & Nelson‐Piercy, C. (2016) · BMJ Case Reports · doi:10.1136/bcr-2016-214798 · Cited by 10
Gent, R., du Toit, T., & Swart, A. C. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.018 · Cited by 10
van Rooyen, D., du Toit, T., Toit, R. L.-D., Africander, D., Swart, P., & Swart, A. C. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.09.025 · Cited by 9
Bae, Y. J., Kratzsch, J., Zeidler, R. B., Fikenzer, S., Werner, C., Herm, J., Jungehulsing, G. J., Endres, M., Hæusler, K. G., Thiery, J., et al. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105473 · Cited by 8
Lumbers, E. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00010-6 · Cited by 9
Mineralocorticoid replacement therapy in salt‐wasting congenital adrenal hyperplasia
Lang, K., Quinkler, M. O., & Kienitz, T. (2023) · Clinical Endocrinology · doi:10.1111/cen.14959 · Cited by 7
“17 In terms of intrinsic activity, judged by induction of gene expression, aldosterone was demonstrated to be the most potent MR agonist.”
InfluentialAndrogen levels are associated with blood pressure in pregnant women after term
Carlsen, S. M., & Heimstad, R. (2011) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2011.01280.x · Cited by 7
“However, progesterone binds to the human mineralocorticoid receptor and exerts both agonistic and antagonistic effects (23).”
BackgroundAbramicheva, P. A., Semenovich, D. S., Zorova, L. D., Pevzner, I. B., Sokolov, I. A., Popkov, V. A., Kazakov, E. P., Zorov, D. B., & Plotnikov, E. Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-39848-2 · Cited by 6
“Progesterone was long believed to exert its effects in the kidney by binding to high-affinity mineralocorticoid receptors 27–29 , until identification of progesterone receptors that are predominantly expressed in kidney tissue, namely the membrane receptors PAQR5 and the nuclear receptors nPR-A and…”
Álvarez, L. D., Dansey, M. V., Marti, M. A., Bertucci, P. Y., Chenna, P. H. D., Pecci, A., & Burton, G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.033 · Cited by 6
Galigniana, M. D., & Pilipuk, G. P. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)69002-9 · Cited by 6
Association of Elevated Serum Aldosterone Concentrations in Pregnancy with Hypertension
Shoemaker, R., Poglitsch, M., Davis, D., Huang, H., Schadler, A. D., Patel, N. B., Vignes, K., Srinivasan, A., Cockerham, C., Bauer, J. A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11112954 · Cited by 5
“Further, highly elevated levels of progesterone in pregnancy may promote aldosterone production independently from the renin–angiotensin system [52] or even interfere with aldosterone signaling through the mineralocorticoid receptor [53].”
BackgroundLotus birth: asking the next question.
Lim, R. (2001) · PubMed · Cited by 5
Unmasking of Gitelman Syndrome during Pregnancy in an Adolescent with Thyrotoxic Crisis
Acharya, R., & Upadhyay, K. K. (2021) · Pediatric Reports · doi:10.3390/pediatric13040075 · Cited by 4
“However, pregnancy typically is associated with retention of potassium, which is thought to be mediated by progesterone due to its mineralocorticoid effect which, in turn, can prevent excess kaliuresis [17,18].”
BackgroundKolli, V., Frucci, E., da Cunha, I. W., Iben, J., Kim, S. A., Mallappa, A., Li, T., Faucz, F. R., Kebebew, E., Nilubol, N., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052543 · Cited by 3
Güngör, K., GÜNGÖR, N. D., Çelik, Ö., Erşahin, A., Çelik, N., Yardım, M., Yurci, A., Kobaner, M., & Maslarski, I. (2024) · Diagnostics · doi:10.3390/diagnostics14192197 · Cited by 3
Relationship between levels of sex hormones and response to cardiac resynchronisation therapy in men
Enina, T. N., Va, K., Soldatova, A. M., Petelina, T. I., Криночкин, Д. В., Dyachkov, S. M., Rychkov, A. Y., & Gorbunova, T. Y. (2018) · Kardiologiia · doi:10.18087/cardio.2464 · Cited by 3
“В экспериментальных работах были показаны кардиопротективные эффекты PGN: иммуносупрессивный [41, 42], антиминералокортикоидный [43, 44], антиапоптотический [45].”
Kang, S., Lee, H., Lee, E., Kim, M., & Kim, I. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12614 · Cited by 3
The Autonomic Nervous System and Its Functions
Lonsdale, D., & Marrs, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810387-6.00002-2 · Cited by 3
Enina, T. N., Евгеньевич, Ш. Н., & Petelina, T. I. (2022) · Journal of Arrhythmology · doi:10.35336/va-2022-2-01 · Cited by 2
Metadata
- Authors
- Quinkler, M., Meyer, B., Bumke-Vogt, C., Grossmann, C., Gruber, U., Oelkers, W., Diederich, S., & Bahr, V
- Affiliations
- Freie Universität Berlin (DE)
- Corresponding author
- Quinkler, M
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-06-01
- Volume
- 146
- Issue
- 6
- Pages
- 789-799
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2165755939
- Cited by
- 130
- References
- 59
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 8 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 8 · 2019: 7 · 2018: 3 · 2017: 7 · 2016: 8 · 2015: 5 · 2014: 10 · 2013: 3 · 2012: 3
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- progesterone metabolites, receptor binding affinity, agonist activity, antagonist activity, 17-hydroxyprogesterone, 20alpha-dihydroprogesterone, 11β-hydroxyprogesterone, aldosterone, mineralocorticoid deficiency, congenital adrenal hyperplasia, pregnancy, transcriptional activation
- MeSH terms
- Aldosterone, Mineralocorticoid Receptor Antagonists, Animals, Desoxycorticosterone, Humans, Hydrocortisone, Luciferases, Progesterone, Rabbits, Reticulocytes, Transcription, Genetic, Transfection, Protein Biosynthesis, Transcriptional Activation, Receptors, Mineralocorticoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review